Data Simulation Enhances Ethical Research Standards

genESOM AI Cuts Animal Drug Testing by 50 Percent

Researchers at Goethe and Marburg universities develop generative AI to simulate pharmacological data points.

By Avantgarde News Desk··1 min read
A laboratory screen displaying 3D molecular models and scientific data graphs in a high-tech medical research setting.

A laboratory screen displaying 3D molecular models and scientific data graphs in a high-tech medical research setting.

Photo: Avantgarde News

Researchers at Goethe University Frankfurt and Marburg University have developed a generative artificial intelligence system called genESOM [1][2]. The technology simulates experimental data points to assist in pharmacological drug discovery [1][3]. By using these simulations, scientists can maintain high statistical significance while conducting fewer physical trials [2].

This new system has successfully reduced the number of mice used in laboratory experiments by 30 to 50 percent [1][2]. genESOM works by augmenting existing datasets, which allows researchers to achieve reliable results with fewer live subjects [3]. The breakthrough provides a more ethical path for future medical research and drug development [1].

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Low

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers data simulation enhances ethical research standards and editorial analysis for Avantgarde News.